Income Statement Orthocell Limited

Equities

OCC

AU000000OCC6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 11:40:19 11/05/2026 am IST			5-day change	1st Jan Change
0.8350 ^AUD	-2.91%		-4.57%	-23.04%

30/04	Orthocell Completes First Commercial Sales of Remplir Nerve Repair Device in Canada	MT
28/04	Orthocell Says Post-Market Follow-Up Study Shows Overall Treatment Success Rate of Nearly 90% for Nerve Repair Product; Shares Jump 4%	MT

70a0838eacba85a7cc971fb70b.OUctypJrG9lgS0k2bejiPTFJDSXwwHJ2o8uJLfFkd1M.QSt3u9dTWZ5UJiZVIYXTCHMzZnqv9j8x0om6VcAAQGJQc3y7zSxhgQd9CA

Published financial data: ORTHOCELL LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	10.18L	15.32L	42.43L	53.15L	75.51L
Total Revenues	10.18L	15.32L	42.43L	53.15L	75.51L
Cost of Goods Sold, Total	6L	7L	10.26L	16.27L	27.46L
Gross Profit	4L	8L	32.17L	36.88L	48.05L
Selling General & Admin Expenses, Total	47.18L	55.35L	59.59L	66.95L	94.14L
R&D Expenses	73.43L	68.18L	75.98L	86.74L	88.19L
Other Operating Expenses	-38.18T	-2.82T	-60.49T	-4L	-4L
Other Operating Expenses, Total	1.2Cr	1.24Cr	1.35Cr	1.5Cr	1.79Cr
Operating Income	-1.16Cr	-1.15Cr	-1.03Cr	-1.13Cr	-1.31Cr
Interest And Investment Income	2L	84.13T	9L	10.32L	13.01L
Net Interest Expenses	2L	84.13T	9L	10.32L	13.01L
Currency Exchange Gains (Loss)	447	2L	18.71T	-	19.27T
EBT, Excl. Unusual Items	-1.14Cr	-1.13Cr	-94.11L	-1.02Cr	-1.18Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-1.14Cr	-1.13Cr	-94.11L	-1.02Cr	-1.18Cr
Income Tax Expense	-23.94L	-21.44L	-31.62L	-30.51L	-31.85L
Earnings From Continuing Operations	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Net Income to Company	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Net Income - (IS)	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Net Income to Common Incl Extra Items	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Net Income to Common Excl. Extra Items	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Per Share Items
Net EPS - Basic	-0.05	-0.05	-0.03	-0.04	-0.04
Basic EPS - Continuing Operations	-0.05	-0.05	-0.03	-0.04	-0.04
Basic Weighted Average Shares Outstanding	19Cr	19Cr	20Cr	20Cr	22Cr
Net EPS - Diluted	-0.05	-0.05	-0.03	-0.04	-0.04
Diluted EPS - Continuing Operations	-0.05	-0.05	-0.03	-0.04	-0.04
Diluted Weighted Average Shares Outstanding	19Cr	19Cr	20Cr	20Cr	22Cr
Normalized Basic EPS	-0.04	-0.04	-0.03	-0.03	-0.03
Normalized Diluted EPS	-0.04	-0.04	-0.03	-0.03	-0.03
Supplemental Items
EBITDA	-1.13Cr	-1.13Cr	-99.25L	-1.09Cr	-1.27Cr
EBITA	-1.14Cr	-1.14Cr	-1.02Cr	-1.12Cr	-1.3Cr
EBIT	-1.16Cr	-1.15Cr	-1.03Cr	-1.13Cr	-1.31Cr
EBITDAR	-1.13Cr	-1.13Cr	-99.22L	-1.09Cr	-1.27Cr
Effective Tax Rate - (Ratio)	20.95	19.06	33.6	29.82	27.1
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-23.94L	-21.44L	-31.62L	-30.51L	-31.85L
Normalized Net Income	-71.45L	-70.32L	-58.82L	-63.95L	-73.45L
Interest on Long-Term Debt	15.27T	20.87T	30.57T	60.52T	52.55T
Supplemental Operating Expense Items
Selling and Marketing Expenses	14.65L	32.98L	17.09L	30.85L	54.61L
General and Administrative Expenses	32.54L	22.37L	42.5L	36.1L	39.53L
Research And Development Expense From Footnotes	73.43L	68.18L	75.98L	86.74L	88.19L
Net Rental Expense, Total	2.55T	2.55T	2.91T	2.94T	2.94T
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	42.99L	5L	24.92L	20.96L	15.4L
Total Stock-Based Compensation	42.99L	5L	24.92L	20.96L	15.4L

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.63Cr	1.1Cr	2.48Cr	2.06Cr	2.86Cr
Total Cash And Short Term Investments	1.63Cr	1.1Cr	2.48Cr	2.06Cr	2.86Cr
Accounts Receivable, Total	2L	2.34Cr	5L	6L	13.24L
Other Receivables	83.74T	1L	4L	6L	5L
Total Receivables	3L	2.35Cr	8L	12.06L	18.47L
Inventory	5L	6L	10.34L	11.77L	12.03L
Prepaid Expenses	10.61T	81.74T	2L	9.71T	2L
Total Current Assets	1.71Cr	3.53Cr	2.69Cr	2.3Cr	3.18Cr
Gross Property Plant And Equipment	16.65L	22.9L	29.33L	38.16L	40.27L
Accumulated Depreciation	-7L	-9L	-13.27L	-12.55L	-16.96L
Net Property Plant And Equipment	9L	14.02L	16.06L	25.62L	23.3L
Other Intangibles, Total	13.24L	12.3L	11.33L	10.46L	10.72L
Total Assets	1.93Cr	3.79Cr	2.96Cr	2.66Cr	3.52Cr
Liabilities
Accounts Payable, Total	9L	32.82L	9L	13.54L	16.89L
Accrued Expenses, Total	8L	9L	11.69L	13.83L	17.4L
Current Portion of Leases	1L	1L	2L	1L	2L
Unearned Revenue Current, Total	-	23.04L	23.04L	23.04L	23.04L
Other Current Liabilities	81.34T	2L	1.28T	1L	5L
Total Current Liabilities	19.34L	68.18L	45.3L	53.06L	64.05L
Long-Term Leases	5L	4L	4L	5L	4L
Unearned Revenue Non Current	-	2.07Cr	1.84Cr	1.61Cr	1.38Cr
Pension & Other Post Retirement Benefits	14.83T	1L	2L	2L	84.84T
Total Liabilities	24.56L	2.8Cr	2.35Cr	2.21Cr	2.07Cr
Common Stock, Total	5.89Cr	6.06Cr	6.1Cr	6.54Cr	8.83Cr
Retained Earnings	-4.51Cr	-5.35Cr	-5.91Cr	-6.56Cr	-7.41Cr
Comprehensive Income and Other	31.33L	28.34L	42.56L	47.37L	4L
Total Common Equity	1.69Cr	99.05L	61.49L	45.33L	1.46Cr
Total Equity	1.69Cr	99.05L	61.49L	45.33L	1.46Cr
Total Liabilities And Equity	1.93Cr	3.79Cr	2.96Cr	2.66Cr	3.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	19Cr	20Cr	20Cr	21Cr	24Cr
ECS Total Common Shares Outstanding	19Cr	20Cr	20Cr	21Cr	24Cr
Book Value / Share	0.09	0.05	0.03	0.02	0.06
Tangible Book Value	1.56Cr	86.75L	50.16L	34.86L	1.35Cr
Tangible Book Value Per Share	0.08	0.04	0.03	0.02	0.06
Total Debt	6L	5L	6L	7L	6L
Net Debt	-1.57Cr	-1.05Cr	-2.43Cr	-1.99Cr	-2.8Cr
Debt Equivalent Oper. Leases	20.42T	20.42T	23.26T	23.52T	23.52T
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	1L	3L	3L	4L	5L
Inventories - Work In Process, Total	80.38T	1L	4L	3L	3L
Inventories - Finished Goods, Total	3L	2L	3L	5L	4L
Machinery, Total	8L	10.43L	12.42L	13.98L	15.42L

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	-90.37L	-91.07L	-62.48L	-71.81L	-85.67L
Depreciation & Amortization - CF	2L	2L	4L	4L	4L
Amortization of Goodwill and Intangible Assets - (CF)	3L	1L	1L	1L	1L
Depreciation & Amortization, Total	4L	3L	6L	5L	5L
Asset Writedown & Restructuring Costs	81.12T	-	-	-77.45T	1.03T
Stock-Based Compensation (CF)	42.99L	5L	24.92L	20.96L	15.4L
Other Operating Activities, Total	24.08T	23T	50.7T	83.04T	94.5T
Change In Accounts Receivable	-10.93T	-2.33Cr	2.1Cr	-3L	-5L
Change In Inventories	-4L	-1L	-4L	-2L	-68.23T
Change In Accounts Payable	1L	22.86L	-7L	5L	5L
Change in Unearned Revenues	-	2.3Cr	-23.04L	-23.58L	-23.04L
Change in Other Net Operating Assets	-88.37T	1L	2L	4L	1L
Cash from Operations	-46.33L	-62.61L	1.46Cr	-65.05L	-86.83L
Capital Expenditure	-2L	-5L	-6L	-9L	-3L
Sale (Purchase) of Intangible assets	-35.65T	-17.83T	-18.12T	-15.13T	-98.64T
Cash from Investing	-2L	-5L	-6L	-9L	-4L
Long-Term Debt Repaid, Total	-	-1L	-2L	-2L	-2L
Total Debt Repaid	-	-1L	-2L	-2L	-2L
Issuance of Common Stock	7L	16.36L	-	35.91L	1.81Cr
Other Financing Activities, Total	-	-	-	-1L	-9L
Cash from Financing	7L	14.89L	-2L	32.44L	1.7Cr
Net Change in Cash	-41.13L	-53.07L	1.38Cr	-42.04L	80.05L
Supplemental Items
Cash Interest Paid	-	-	-	2.08T	14T
Cash Income Tax Paid (Refund)	-23.94L	-21.44L	-31.62L	-30.51L	-31.85L
Levered Free Cash Flow	-30.37L	-2.55Cr	1.58Cr	-49.06L	-61.81L
Unlevered Free Cash Flow	-30.37L	-2.55Cr	1.58Cr	-49.06L	-61.81L
Change In Net Working Capital	3L	1.86Cr	-1.98Cr	-5L	-3L
Net Debt Issued / Repaid	-	-1L	-2L	-2L	-2L

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	-34.21	-25.17	-19.04	-25.04	-26.42
Return on Total Capital	-37.37	-51.61	-75.04	-117.99	-80.22
Return On Equity %	-47.84	-68.01	-77.84	-134.46	-89.7
Return on Common Equity	-47.84	-68.01	-77.84	-134.46	-89.7
Margin Analysis
Gross Profit Margin %	38.54	54.13	75.82	69.39	63.63
SG&A Margin	463.5	361.39	140.45	125.96	124.68
EBITDA Margin %	-1.11T	-737.55	-233.91	-205.25	-168.14
EBITA Margin %	-1.12T	-744.94	-239.57	-209.88	-171.66
EBIT Margin %	-1.14T	-752.21	-242.28	-211.92	-173.12
Income From Continuing Operations Margin %	-887.76	-594.53	-147.26	-135.1	-113.46
Net Income Margin %	-887.76	-594.53	-147.26	-135.1	-113.46
Net Avail. For Common Margin %	-887.76	-594.53	-147.26	-135.1	-113.46
Normalized Net Income Margin	-701.86	-459.07	-138.62	-120.32	-97.27
Levered Free Cash Flow Margin	-298.32	-1.67T	373.22	-92.3	-81.85
Unlevered Free Cash Flow Margin	-298.32	-1.67T	373.22	-92.3	-81.85
Asset Turnover
Asset Turnover	0.05	0.05	0.13	0.19	0.24
Fixed Assets Turnover	1.22	1.31	2.82	2.55	3.09
Receivables Turnover (Average Receivables)	8.77	0.13	0.36	9.9	7.85
Inventory Turnover (Average Inventory)	2.42	1.3	1.25	1.47	2.31
Short Term Liquidity
Current Ratio	8.83	5.17	5.93	4.34	4.97
Quick Ratio	8.58	5.07	5.66	4.11	4.76
Operating Cash Flow to Current Liabilities	-2.4	-0.92	3.22	-1.23	-1.36
Days Sales Outstanding (Average Receivables)	41.61	2.81T	1.03T	36.97	46.51
Days Outstanding Inventory (Average Inventory)	150.64	281.16	293.04	248.67	158.16
Average Days Payable Outstanding	293.31	899.26	524.54	230.56	200.29
Cash Conversion Cycle (Average Days)	-101.06	2.19T	796.55	55.07	4.38
Long Term Solvency
Total Debt/Equity	3.68	5.12	9.14	15.22	3.96
Total Debt / Total Capital	3.55	4.87	8.38	13.21	3.81
LT Debt/Equity	3.01	3.91	6.21	11.93	2.82
Long-Term Debt / Total Capital	2.9	3.72	5.69	10.35	2.72
Total Liabilities / Total Assets	12.71	73.86	79.23	82.97	58.65
Total Debt / EBITDA	-0.06	-0.05	-0.06	-0.06	-0.05
Net Debt / EBITDA	1.4	0.94	2.49	1.85	2.24
Total Debt / (EBITDA - Capex)	-0.05	-0.04	-0.05	-0.06	-0.05
Net Debt / (EBITDA - Capex)	1.38	0.9	2.35	1.71	2.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	41.48	50.47	177.01	25.27	42.05
Gross Profit, 1 Yr. Growth %	83.2	111.34	288	14.66	30.27
EBITDA, 1 Yr. Growth %	26.75	0.01	-12.15	9.92	16.37
EBITA, 1 Yr. Growth %	26.74	0.35	-10.91	9.75	16.18
EBIT, 1 Yr. Growth %	26.81	-0.94	-10.78	9.57	16.05
Earnings From Cont. Operations, 1 Yr. Growth %	46.92	0.77	-31.39	14.93	19.3
Net Income, 1 Yr. Growth %	46.92	0.77	-31.39	14.93	19.3
Normalized Net Income, 1 Yr. Growth %	26.24	-1.58	-16.35	8.73	14.85
Diluted EPS Before Extra, 1 Yr. Growth %	34.34	-2.82	-31.91	12.5	6.59
Accounts Receivable, 1 Yr. Growth %	248.07	12.89T	-97.98	26.59	120.76
Inventory, 1 Yr. Growth %	886.05	30.86	68.54	13.78	2.23
Net Property, Plant and Equip., 1 Yr. Growth %	27.05	50.03	14.56	59.51	-9.04
Total Assets, 1 Yr. Growth %	-16.57	96.04	-21.88	-10.1	32.39
Tangible Book Value, 1 Yr. Growth %	-19.32	-44.22	-42.18	-30.49	287.12
Common Equity, 1 Yr. Growth %	-19.27	-41.3	-37.92	-26.29	221.43
Cash From Operations, 1 Yr. Growth %	-11.86	38.59	-333.05	-144.58	33.48
Capital Expenditures, 1 Yr. Growth %	2.01T	238.33	18.61	51.1	-71.9
Levered Free Cash Flow, 1 Yr. Growth %	-38.58	739.93	-162.08	-130.98	25.97
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.58	739.93	-162.08	-130.98	25.97
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.75	45.9	104.16	86.28	33.4
Gross Profit, 2 Yr. CAGR %	35.61	96.76	186.35	110.92	22.21
EBITDA, 2 Yr. CAGR %	16.68	12.59	-6.26	-1.73	13.1
EBITA, 2 Yr. CAGR %	16.6	12.78	-5.45	-1.12	12.92
EBIT, 2 Yr. CAGR %	16.86	12.08	-5.99	-1.12	12.76
Earnings From Cont. Operations, 2 Yr. CAGR %	24.27	21.68	-16.85	-11.2	17.09
Net Income, 2 Yr. CAGR %	24.27	21.68	-16.85	-11.2	17.09
Normalized Net Income, 2 Yr. CAGR %	15.93	11.46	-9.27	-4.63	11.75
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.09	14.26	-18.66	-12.48	9.5
Accounts Receivable, 2 Yr. CAGR %	54.91	2.03T	62.12	-84	67.17
Inventory, 2 Yr. CAGR %	192.96	259.21	48.51	38.48	7.85
Net Property, Plant and Equip., 2 Yr. CAGR %	80.38	38.06	31.1	35.18	20.45
Total Assets, 2 Yr. CAGR %	19.23	27.89	23.76	-16.2	9.1
Tangible Book Value, 2 Yr. CAGR %	31.87	-32.91	-43.21	-36.6	64.04
Common Equity, 2 Yr. CAGR %	25.44	-31.16	-39.63	-32.35	53.93
Cash From Operations, 2 Yr. CAGR %	5.28	9.14	79.72	1.93	-22.86
Capital Expenditures, 2 Yr. CAGR %	228.63	744.03	100.32	33.87	-34.84
Levered Free Cash Flow, 2 Yr. CAGR %	-9.28	127.13	128.36	-56.14	-37.53
Unlevered Free Cash Flow, 2 Yr. CAGR %	-9.28	127.13	128.36	-56.14	-37.53
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.02	17.44	80.67	73.49	70.19
Gross Profit, 3 Yr. CAGR %	38	57.23	146.74	111.06	79.62
EBITDA, 3 Yr. CAGR %	12.95	10.83	3.66	-1.15	3.97
EBITA, 3 Yr. CAGR %	12.84	10.91	4.25	-0.63	4.34
EBIT, 3 Yr. CAGR %	13.14	10.6	3.88	-1.06	4.3
Earnings From Cont. Operations, 3 Yr. CAGR %	16.22	15.88	0.52	-7.38	-2.02
Net Income, 3 Yr. CAGR %	16.22	15.88	0.52	-7.38	-2.02
Normalized Net Income, 3 Yr. CAGR %	12.59	9.77	1.29	-3.63	1.46
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.19	-1.67	-3.85	-9.37	-6.54
Accounts Receivable, 3 Yr. CAGR %	17.55	578.11	109.14	49.29	-61.62
Inventory, 3 Yr. CAGR %	105.77	123.95	179.13	35.89	25.16
Net Property, Plant and Equip., 3 Yr. CAGR %	39.93	69.64	29.73	39.96	18.45
Total Assets, 3 Yr. CAGR %	54.61	40.73	8.51	11.25	-2.4
Tangible Book Value, 3 Yr. CAGR %	179.48	-1.01	-36.16	-39.25	15.87
Common Equity, 3 Yr. CAGR %	92.32	-2.62	-33.49	-35.48	13.73
Cash From Operations, 3 Yr. CAGR %	-0.08	14.42	40.54	12.92	11.51
Capital Expenditures, 3 Yr. CAGR %	20.59	231.83	338.81	82.35	-20.44
Levered Free Cash Flow, 3 Yr. CAGR %	-10.19	90.5	47.4	17.34	-37.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	-10.19	90.5	47.4	17.34	-37.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.84	23.65	46.95	41.24	60.03
Gross Profit, 5 Yr. CAGR %	18.36	55.33	84.79	76.83	86.29
EBITDA, 5 Yr. CAGR %	16.54	13.43	4.83	5.63	7.33
EBITA, 5 Yr. CAGR %	16.48	13.39	5.13	5.93	7.64
EBIT, 5 Yr. CAGR %	16.78	13.32	5.06	5.75	7.34
Earnings From Cont. Operations, 5 Yr. CAGR %	19.01	16.87	1.65	4.18	6.85
Net Income, 5 Yr. CAGR %	19.01	16.87	1.65	4.18	6.85
Normalized Net Income, 5 Yr. CAGR %	16.65	12.93	3.28	3.77	5.35
Diluted EPS Before Extra, 5 Yr. CAGR %	2.37	1.75	-10.27	-6.15	1.28
Accounts Receivable, 5 Yr. CAGR %	7.45	265.92	33.68	51.51	91.22
Inventory, 5 Yr. CAGR %	28.44	47.33	80.61	84.77	90.82
Net Property, Plant and Equip., 5 Yr. CAGR %	26.44	31.41	36.33	54.91	25.94
Total Assets, 5 Yr. CAGR %	22.13	39.56	41.44	14.38	8.75
Tangible Book Value, 5 Yr. CAGR %	33.84	22.1	47.75	-17.17	-6.88
Common Equity, 5 Yr. CAGR %	28.14	16.02	20.98	-15.82	-6.97
Cash From Operations, 5 Yr. CAGR %	6.89	11.98	25.73	9.25	10.56
Capital Expenditures, 5 Yr. CAGR %	30.14	36.8	47.73	130.79	104.62
Levered Free Cash Flow, 5 Yr. CAGR %	-0.38	50.1	30.45	5.86	4.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.38	50.1	30.45	5.86	4.56